NewslettersPancreatic Cell NewsOpen Letter Regarding the Use of Mounjaro® and Zepbound™By Laurisa Dohm - January 12, 20240109Lilly Stands Against the Use of its Medicines for Cosmetic Weight Loss: Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for – and should not be used for – cosmetic weight loss.[Eli Lilly]Press Release